New drug ZT003 enters first human safety trials
NCT ID NCT07184502
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 32 times
Summary
This early-stage study tests whether ZT003 is safe and how it moves through the body in healthy adults and those who are overweight. About 76 participants will receive either the drug or a placebo. The goal is to check for side effects and measure drug levels, not to treat any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Nucleus Network Brisbane
RECRUITINGBrisbane, Queensland, Australia
Contact
Conditions
Explore the condition pages connected to this study.